It is intended to provide an inhibitor for the formation of a
.gamma.-secretase complex which comprises a cholesterol synthesis
inhibitor or a protein geranylgeranylation regulator as the active
ingredient; and use of a cholesterol synthesis inhibitor or a protein
geranylgeranylation regulator for producing the same. It is also intended
to provide a method of screening a substance having an effect of
inhibiting the formation of an active complex of .gamma.-secretase which
comprises assaying the activity of inhibiting cholesterol synthesis or
quantifying cholesterol accumulated in lipid rafts in cells. It is also
intended to provide a method of screening a cholesterol synthesis
inhibitor, a protein geranylgeranylation regulator or an HMG-CoA
reductase inhibitor which comprises assaying the effect of inhibiting the
formation of an active complex of .gamma.-secretase. Moreover, it is
intended to provide a method of screening an effect of a test substance
on .gamma.-secretase which comprises measuring the distribution of
constituents (niscastrin, APH-1, Pen-2 and so on) required by
.gamma.-secretase for the formation of its active complex in cells.